182 related articles for article (PubMed ID: 14517838)
1. Reduced expression of oestrogen receptor beta in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line model.
Skliris GP; Munot K; Bell SM; Carder PJ; Lane S; Horgan K; Lansdown MR; Parkes AT; Hanby AM; Markham AF; Speirs V
J Pathol; 2003 Oct; 201(2):213-20. PubMed ID: 14517838
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.
Borges S; Döppler H; Perez EA; Andorfer CA; Sun Z; Anastasiadis PZ; Thompson E; Geiger XJ; Storz P
Breast Cancer Res; 2013 Aug; 15(2):R66. PubMed ID: 23971832
[TBL] [Abstract][Full Text] [Related]
3. Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines.
Yan L; Nass SJ; Smith D; Nelson WG; Herman JG; Davidson NE
Cancer Biol Ther; 2003; 2(5):552-6. PubMed ID: 14614325
[TBL] [Abstract][Full Text] [Related]
4. c-myc amplifications in primary breast carcinomas and their local recurrences.
Aulmann S; Adler N; Rom J; Helmchen B; Schirmacher P; Sinn HP
J Clin Pathol; 2006 Apr; 59(4):424-8. PubMed ID: 16497871
[TBL] [Abstract][Full Text] [Related]
5. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S
Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207
[TBL] [Abstract][Full Text] [Related]
6. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma.
Zekioglu O; Erhan Y; Ciris M; Bayramoglu H; Ozdemir N
Histopathology; 2004 Jan; 44(1):18-23. PubMed ID: 14717664
[TBL] [Abstract][Full Text] [Related]
7. NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas.
Asch-Kendrick RJ; Samols MA; Lilo MT; Subhawong AP; Sharma R; Illei PB; Argani P; Cimino-Mathews A
J Clin Pathol; 2014 Sep; 67(9):768-71. PubMed ID: 24996432
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Oncotype DX and TAILORx risk categories using histopathological and immunohistochemical markers by classification and regression tree (CART) analysis.
Ingoldsby H; Webber M; Wall D; Scarrott C; Newell J; Callagy G
Breast; 2013 Oct; 22(5):879-86. PubMed ID: 23643806
[TBL] [Abstract][Full Text] [Related]
9. ADAM33 gene silencing by promoter hypermethylation as a molecular marker in breast invasive lobular carcinoma.
Seniski GG; Camargo AA; Ierardi DF; Ramos EA; Grochoski M; Ribeiro ES; Cavalli IJ; Pedrosa FO; de Souza EM; Zanata SM; Costa FF; Klassen G
BMC Cancer; 2009 Mar; 9():80. PubMed ID: 19267929
[TBL] [Abstract][Full Text] [Related]
10. Methylation-mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells.
Jhaveri MS; Morrow CS
Gene; 1998 Mar; 210(1):1-7. PubMed ID: 9524203
[TBL] [Abstract][Full Text] [Related]
11. Frequent epigenetic inactivation of the receptor tyrosine kinase EphA5 by promoter methylation in human breast cancer.
Fu DY; Wang ZM; Wang BL; Chen L; Yang WT; Shen ZZ; Huang W; Shao ZM
Hum Pathol; 2010 Jan; 41(1):48-58. PubMed ID: 19733895
[TBL] [Abstract][Full Text] [Related]
12. DAX-1 expression in human breast cancer: comparison with estrogen receptors ER-alpha, ER-beta and androgen receptor status.
Conde I; Alfaro JM; Fraile B; Ruíz A; Paniagua R; Arenas MI
Breast Cancer Res; 2004; 6(3):R140-8. PubMed ID: 15084237
[TBL] [Abstract][Full Text] [Related]
13. CpG hypermethylation of the promoter region inactivates the estrogen receptor-beta gene in patients with prostate carcinoma.
Nojima D; Li LC; Dharia A; Perinchery G; Ribeiro-Filho L; Yen TS; Dahiya R
Cancer; 2001 Oct; 92(8):2076-83. PubMed ID: 11596023
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor alpha and beta profiling in human breast cancer.
Balfe P; McCann A; McGoldrick A; McAllister K; Kennedy M; Dervan P; Kerin MJ
Eur J Surg Oncol; 2004 Jun; 30(5):469-74. PubMed ID: 15135471
[TBL] [Abstract][Full Text] [Related]
15. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer.
Lehmann U; Hasemeier B; Christgen M; Müller M; Römermann D; Länger F; Kreipe H
J Pathol; 2008 Jan; 214(1):17-24. PubMed ID: 17948228
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial UCP4 and bcl-2 expression in imprints of breast carcinomas: relationship with DNA ploidy and classical prognostic factors.
Gonidi M; Athanassiadou AM; Patsouris E; Tsipis A; Dimopoulos S; Kyriakidou V; Chelidonis G; Athanassiadou P
Pathol Res Pract; 2011 Jun; 207(6):377-82. PubMed ID: 21621926
[TBL] [Abstract][Full Text] [Related]
18. Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines.
Tong D; Schuster E; Seifert M; Czerwenka K; Leodolte S; Zeillinger R
Breast Cancer Res Treat; 2002 Feb; 71(3):249-55. PubMed ID: 12002343
[TBL] [Abstract][Full Text] [Related]
19. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
[TBL] [Abstract][Full Text] [Related]
20. RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype.
Habashy HO; Powe DG; Glaab E; Ball G; Spiteri I; Krasnogor N; Garibaldi JM; Rakha EA; Green AR; Caldas C; Ellis IO
Breast Cancer Res Treat; 2011 Jul; 128(2):315-26. PubMed ID: 20697807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]